首页 > 市场调查报告书 > 材料

市场调查报告书

商品编码

1641734

全球细胞培养水凝胶市场按水凝胶类型、应用和最终用户划分 - 机会分析和产业预测（2024-2035 年）

Cell Culture Hydrogel Market By Type of Hydrogel, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2024-2035

出版日期: 2024年12月01日 | 出版商:

Allied Market Research | 英文 321 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计 2023 年全球细胞培养水凝胶市场规模将达到 4 亿美元，到 2035 年将达到 21.367 亿美元，2024 年至 2035 年的复合年增长率为 15.0%。

细胞培养水凝胶是一种三维、富水的聚合物材料，旨在模拟细胞外基质（ECM）环境以在试管内培养细胞。这些水凝胶提供维持细胞功能、增殖和分化所必需的结构支撑、生化线索和机械性能。水凝胶常用于生物医学研究，包括组织工程、再生医学和药物发现。

人们对干细胞治疗和研究的日益关注是推动水凝胶需求的关键因素，水凝胶透过模仿原生细胞环境来支持干细胞的生长和分化。此外，药物筛检、类器官发育和再生医学中从二维到三维细胞培养的转变显着增加了对水凝胶的需求。研究表明，与传统的 Matrigel 支架相比，以具有可调机械性能的合成水凝胶为支撑的类器官培养物更具可重复性，并且能更准确地模拟器官样结构。此外，药物发现和开发中的应用正在推动市场发展。这是因为水凝胶能够开发用于高通量药物筛检的 3D 模型，从而促进其在製药和生物技术行业的应用。此外，研究癌症、心血管疾病和糖尿病等慢性疾病对先进体外模型的需求日益增长，推动了生物医学研究中对水凝胶的需求。世界卫生组织（WHO）2023年的研究显示，每年约有4,100万人死于慢性病。器官晶片技术日益被采用，该技术通常采用水凝胶来模拟组织微环境，这进一步推动了市场的发展。然而，针对特定应用客製化水凝胶的特性（例如硬度、孔隙率和降解率）需要技术专长和时间，这对市场的成长造成了阻碍。此外，替代性 3D 培养方法（例如基于微载体的细胞培养和球体等无支架方法）的可用性也可能对市场成长构成挑战。相反，水凝胶配方的创新，例如具有可调特性和刺激响应行为的智慧水凝胶，正在扩大其功能和应用。组织工程和再生医学领域不断增加的研究和临床努力正在推动对水凝胶作为创建功能性组织结构的主要生物材料的需求。预计这些发展将为预测期内全球市场的扩张提供有利机会。

细胞培养水凝胶市场根据水凝胶的类型、应用、最终用户和地区进行细分。根据水凝胶类型，市场分为天然水凝胶、合成水凝胶和混合水凝胶。根据应用，可分为癌症和干细胞研究、组织工程和再生医学、药物发现和毒性测试等。根据最终用户，市场分为製药和生技公司、CRO、研究机构等。依地区划分，北美（美国、加拿大、墨西哥）、欧洲（德国、法国、英国、义大利、西班牙等）、亚太地区（日本、中国、印度、澳洲、韩国等）、拉丁美洲、中东、非洲分析分为四个国家（巴西、南非、沙乌地阿拉伯等）。

主要发现

根据水凝胶类型，合成水凝胶预计将在 2023 年占据市场份额的主导地位，并在 2024 年至 2035 年期间实现最高复合年增长率。

根据应用，组织工程和再生医学领域预计将在 2023 年占据最大份额，而癌症和干细胞研究领域预计将在预测期内以最高的复合年增长率增长。

根据最终用户，製药和生物技术公司部门将成为 2023 年的领先部门，而 CRO 部门预计将在预测期内实现最高的复合年增长率。

根据地区，北美是 2023 年全球细胞培养水凝胶市场最大的地区，而亚太地区预计在预测期内实现最高的复合年增长率。

竞争分析

第四章细胞培养水凝胶市场（按水凝胶类型）

概述
天然水凝胶
合成水凝胶
混合水凝胶

第五章细胞培养水凝胶市场（依应用）

概述
癌症和干细胞研究
组织工程与再生医学
药物研发和毒性测试
其他的

第六章细胞培养水凝胶市场（依最终用户）

概述
製药和生物技术公司
CRO
研究所
其他的

7. 细胞培养水凝胶市场（按地区）

概述
北美洲
- 美国
- 加拿大
- 墨西哥
欧洲
- 德国
- 法国
- 英国
- 义大利
- 西班牙
- 其他的
亚太地区
- 日本
- 中国
- 澳洲
- 印度
- 韩国
- 其他的
拉丁美洲、中东和非洲
- 巴西
- 沙乌地阿拉伯
- 南非
- 其他的

第八章竞争格局

介绍
关键成功策略
前 10 家公司的产品映射
竞争仪錶板
竞争热图
主要企业定位（2023年）

第九章公司简介

Corning Incorporated
Merck KGaA
Humabiologics, Inc
BICO
TheWell Bioscience Inc.
CD Bioparticles
PELOBIOTECH GmbH
Cell Guidance Systems
UPM
Cellendes GmbH

简介目录

Product Code: A325248

The cell culture hydrogel market was valued at $400.0 million in 2023 and is estimated to reach $2,136.7 million by 2035, exhibiting a CAGR of 15.0% from 2024 to 2035.

Cell culture hydrogel is a three-dimensional, water-rich polymeric materials designed to mimic the extracellular matrix (ECM) environment for culturing cells in vitro. These hydrogels provide structural support, biochemical cues, and mechanical properties essential for maintaining cellular function, proliferation, and differentiation. They are commonly used in biomedical research, including tissue engineering, regenerative medicine, and drug discovery.

Increase in focus on stem cell therapies and research is a key factors that has fueled the demand for hydrogels, which support stem cell growth and differentiation by mimicking natural cellular environments. In addition, the transition from 2D to 3D cell cultures for drug screening, organoid development, and regenerative medicine has significantly increased the demand for hydrogels. Studies have shown that organoid cultures supported by synthetic hydrogels with tunable mechanical properties enhance reproducibility and mimic organ-like structures more accurately compared to traditional Matrigel scaffolds. Moreover, rising applications in drug discovery and development fuel the growth of the market. This is attributed to the fact that hydrogels enable the development of 3D models for high-throughput drug screening, enhancing their adoption by pharmaceutical and biotechnology industries. Furthermore, rise in need for advanced in vitro models to study chronic diseases like cancer, cardiovascular conditions, and diabetes is fueling the demand for hydrogels in biomedical research. A 2023 study published by the World Health Organization revealed that approximately 41 million individuals die each year due to chronic diseases. Rise in adoption of organ-on-a-chip technologies, which often incorporate hydrogels to simulate tissue microenvironments, further propels the market. However, requirement for tailoring hydrogel properties, such as stiffness, porosity, and degradation rate, to suit specific applications demands technical expertise and time, which acts as a barrier for the market growth. Moreover, availability of alternative 3D culture methods such as microcarrier-based cell cultures or scaffold-free methods like spheroids, can pose challenges to the market growth. On the contrary, innovations in hydrogel formulations, such as smart hydrogels with tunable properties and stimuli-responsive behavior, are expanding their functionality and applications. Rise in research and clinical efforts in tissue engineering and regenerative medicine are boosting the demand for hydrogels, which serve as key biomaterials for creating functional tissue constructs. Such developments are expected to offer lucrative opportunities for the expansion of the global market during the forecast period.

The cell culture hydrogel market is segmented into type of hydrogel, application, end user, and region. By type of hydrogel, the market is segmented into natural hydrogels, synthetic hydrogels, hybrid hydrogels. By application, the market is segmented into cancer and stem cell research, tissue engineering and regenerative medicine, drug discovery and toxicology testing, and others. By end user, the market is segregated into pharmaceutical and biotechnology companies, CROs, research institution, and others. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).

Key Findings

Depending on type of hydrogel, the synthetic hydrogels segment dominated the share, in terms of share, in 2023, and is expected to register the highest CAGR from 2024 to 2035.

On the basis of application, the tissue engineering & regenerative medicine segment garnered the largest share in 2023; however, the cancer & stem cell research segment is expected to grow at the highest CAGR during the forecast period.

By end user, the pharmaceutical and biotechnology companies segment was the major shareholder in 2023; however, the CROs segment is anticipated to exhibit the highest CAGR during the forecast period.

Region wise, North America was the largest shareholder in the global cell culture hydrogel market in 2023; however, Asia-Pacific is anticipated to register the highest CAGR during the forecast period.

Competitive Analysis

The key players that operate in the global cell culture hydrogel market are Corning Incorporated, Merck KGaA, Humabiologics, Inc, Cell Guidance Systems, TheWell Bioscience Inc., CD Bioparticles, BICO, PELOBIOTECH GmbH, UPM, and Cellendes GmbH. These players have adopted expansion, agreement, partnership, and collaboration as their key strategies to strengthen their foothold in the global market

Key Benefits for Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cell culture hydrogel market analysis from 2023 to 2035 to identify the prevailing cell culture hydrogel market opportunities.

The market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

In-depth analysis of the cell culture hydrogel market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes the analysis of the regional as well as global cell culture hydrogel market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Market share analysis of players by products/segments
New Product Development/ Product Matrix of Key Players
Additional company profiles with specific to client's interest
Expanded list for Company Profiles
Historic market data

Key Market Segments

By Type of Hydrogel

Synthetic Hydrogels
Hybrid Hydrogels
Natural Hydrogels

By Application

Cancer and Stem Cell Research
Tissue Engineering and Regenerative Medicine
Drug Discovery and Toxicology Testing
Others

By End User

Research Institutions
Others
Pharmaceutical and Biotechnology Companies
CROs

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Key Market Players:

Corning Incorporated
Merck KGaA
Humabiologics, Inc
UPM
PELOBIOTECH GmbH
CD Bioparticles
Cell Guidance Systems
BICO
TheWell Bioscience Inc.
Cellendes GmbH

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
- 3.3.1. Moderate bargaining power of suppliers
- 3.3.2. Moderate threat of new entrants
- 3.3.3. Moderate threat of substitutes
- 3.3.4. Moderate intensity of rivalry
- 3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
- 3.4.1. Drivers
  - 3.4.1.1. Applications in drug discovery and toxicology testing
  - 3.4.1.2. Rise in prevalence of chronic diseases and aging population
  - 3.4.1.3. Rise in demand for 3D cell culture
- 3.4.2. Restraints
  - 3.4.2.1. Lack of a skilled workforce
- 3.4.3. Opportunities
  - 3.4.3.1. High growth potential in emerging markets
  - 3.4.3.2. Advancements in biotechnology and life sciences

CHAPTER 4: CELL CULTURE HYDROGEL MARKET, BY TYPE OF HYDROGEL

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Natural Hydrogels
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. Synthetic Hydrogels
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
4.4. Hybrid Hydrogels
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country

CHAPTER 5: CELL CULTURE HYDROGEL MARKET, BY APPLICATION

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Cancer and Stem Cell Research
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Tissue Engineering and Regenerative Medicine
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
5.4. Drug Discovery and Toxicology Testing
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
5.5. Others
- 5.5.1. Key market trends, growth factors and opportunities
- 5.5.2. Market size and forecast, by region
- 5.5.3. Market share analysis by country

CHAPTER 6: CELL CULTURE HYDROGEL MARKET, BY END USER

6.1. Overview
- 6.1.1. Market size and forecast
6.2. Pharmaceutical and Biotechnology Companies
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
6.3. CROs
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
6.4. Research Institutions
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country
6.5. Others
- 6.5.1. Key market trends, growth factors and opportunities
- 6.5.2. Market size and forecast, by region
- 6.5.3. Market share analysis by country

CHAPTER 7: CELL CULTURE HYDROGEL MARKET, BY REGION

7.1. Overview
- 7.1.1. Market size and forecast By Region
7.2. North America
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by Type of Hydrogel
- 7.2.3. Market size and forecast, by Application
- 7.2.4. Market size and forecast, by End User
- 7.2.5. Market size and forecast, by country
  - 7.2.5.1. U.S.
  - 7.2.5.1.1. Market size and forecast, by Type of Hydrogel
  - 7.2.5.1.2. Market size and forecast, by Application
  - 7.2.5.1.3. Market size and forecast, by End User
  - 7.2.5.2. Canada
  - 7.2.5.2.1. Market size and forecast, by Type of Hydrogel
  - 7.2.5.2.2. Market size and forecast, by Application
  - 7.2.5.2.3. Market size and forecast, by End User
  - 7.2.5.3. Mexico
  - 7.2.5.3.1. Market size and forecast, by Type of Hydrogel
  - 7.2.5.3.2. Market size and forecast, by Application
  - 7.2.5.3.3. Market size and forecast, by End User
7.3. Europe
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by Type of Hydrogel
- 7.3.3. Market size and forecast, by Application
- 7.3.4. Market size and forecast, by End User
- 7.3.5. Market size and forecast, by country
  - 7.3.5.1. Germany
  - 7.3.5.1.1. Market size and forecast, by Type of Hydrogel
  - 7.3.5.1.2. Market size and forecast, by Application
  - 7.3.5.1.3. Market size and forecast, by End User
  - 7.3.5.2. France
  - 7.3.5.2.1. Market size and forecast, by Type of Hydrogel
  - 7.3.5.2.2. Market size and forecast, by Application
  - 7.3.5.2.3. Market size and forecast, by End User
  - 7.3.5.3. UK
  - 7.3.5.3.1. Market size and forecast, by Type of Hydrogel
  - 7.3.5.3.2. Market size and forecast, by Application
  - 7.3.5.3.3. Market size and forecast, by End User
  - 7.3.5.4. Italy
  - 7.3.5.4.1. Market size and forecast, by Type of Hydrogel
  - 7.3.5.4.2. Market size and forecast, by Application
  - 7.3.5.4.3. Market size and forecast, by End User
  - 7.3.5.5. Spain
  - 7.3.5.5.1. Market size and forecast, by Type of Hydrogel
  - 7.3.5.5.2. Market size and forecast, by Application
  - 7.3.5.5.3. Market size and forecast, by End User
  - 7.3.5.6. Rest of Europe
  - 7.3.5.6.1. Market size and forecast, by Type of Hydrogel
  - 7.3.5.6.2. Market size and forecast, by Application
  - 7.3.5.6.3. Market size and forecast, by End User
7.4. Asia-Pacific
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by Type of Hydrogel
- 7.4.3. Market size and forecast, by Application
- 7.4.4. Market size and forecast, by End User
- 7.4.5. Market size and forecast, by country
  - 7.4.5.1. Japan
  - 7.4.5.1.1. Market size and forecast, by Type of Hydrogel
  - 7.4.5.1.2. Market size and forecast, by Application
  - 7.4.5.1.3. Market size and forecast, by End User
  - 7.4.5.2. China
  - 7.4.5.2.1. Market size and forecast, by Type of Hydrogel
  - 7.4.5.2.2. Market size and forecast, by Application
  - 7.4.5.2.3. Market size and forecast, by End User
  - 7.4.5.3. Australia
  - 7.4.5.3.1. Market size and forecast, by Type of Hydrogel
  - 7.4.5.3.2. Market size and forecast, by Application
  - 7.4.5.3.3. Market size and forecast, by End User
  - 7.4.5.4. India
  - 7.4.5.4.1. Market size and forecast, by Type of Hydrogel
  - 7.4.5.4.2. Market size and forecast, by Application
  - 7.4.5.4.3. Market size and forecast, by End User
  - 7.4.5.5. South Korea
  - 7.4.5.5.1. Market size and forecast, by Type of Hydrogel
  - 7.4.5.5.2. Market size and forecast, by Application
  - 7.4.5.5.3. Market size and forecast, by End User
  - 7.4.5.6. Rest of Asia-Pacific
  - 7.4.5.6.1. Market size and forecast, by Type of Hydrogel
  - 7.4.5.6.2. Market size and forecast, by Application
  - 7.4.5.6.3. Market size and forecast, by End User
7.5. LAMEA
- 7.5.1. Key market trends, growth factors and opportunities
- 7.5.2. Market size and forecast, by Type of Hydrogel
- 7.5.3. Market size and forecast, by Application
- 7.5.4. Market size and forecast, by End User
- 7.5.5. Market size and forecast, by country
  - 7.5.5.1. Brazil
  - 7.5.5.1.1. Market size and forecast, by Type of Hydrogel
  - 7.5.5.1.2. Market size and forecast, by Application
  - 7.5.5.1.3. Market size and forecast, by End User
  - 7.5.5.2. Saudi Arabia
  - 7.5.5.2.1. Market size and forecast, by Type of Hydrogel
  - 7.5.5.2.2. Market size and forecast, by Application
  - 7.5.5.2.3. Market size and forecast, by End User
  - 7.5.5.3. South Africa
  - 7.5.5.3.1. Market size and forecast, by Type of Hydrogel
  - 7.5.5.3.2. Market size and forecast, by Application
  - 7.5.5.3.3. Market size and forecast, by End User
  - 7.5.5.4. Rest of LAMEA
  - 7.5.5.4.1. Market size and forecast, by Type of Hydrogel
  - 7.5.5.4.2. Market size and forecast, by Application
  - 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2023

CHAPTER 9: COMPANY PROFILES

9.1. Corning Incorporated
- 9.1.1. Company overview
- 9.1.2. Key executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.1.6. Business performance
9.2. Merck KGaA
- 9.2.1. Company overview
- 9.2.2. Key executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
- 9.2.6. Business performance
- 9.2.7. Key strategic moves and developments
9.3. Humabiologics, Inc
- 9.3.1. Company overview
- 9.3.2. Key executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
- 9.3.6. Key strategic moves and developments
9.4. BICO
- 9.4.1. Company overview
- 9.4.2. Key executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
- 9.4.6. Business performance
9.5. TheWell Bioscience Inc.
- 9.5.1. Company overview
- 9.5.2. Key executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
- 9.5.6. Key strategic moves and developments
9.6. CD Bioparticles
- 9.6.1. Company overview
- 9.6.2. Key executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
9.7. PELOBIOTECH GmbH
- 9.7.1. Company overview
- 9.7.2. Key executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
9.8. Cell Guidance Systems
- 9.8.1. Company overview
- 9.8.2. Key executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
9.9. UPM
- 9.9.1. Company overview
- 9.9.2. Key executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
- 9.9.6. Business performance
- 9.9.7. Key strategic moves and developments
9.10. Cellendes GmbH
- 9.10.1. Company overview
- 9.10.2. Key executives
- 9.10.3. Company snapshot
- 9.10.4. Operating business segments
- 9.10.5. Product portfolio

02-2729-4219

+886-2-2729-4219

License/价格

全球细胞培养水凝胶市场按水凝胶类型、应用和最终用户划分 - 机会分析和产业预测（2024-2035 年）

Cell Culture Hydrogel Market By Type of Hydrogel, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2024-2035